Document Detail

Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease.
MedLine Citation:
PMID:  22397469     Owner:  NLM     Status:  MEDLINE    
Blockade of the MR (mineralocorticoid receptor) in CKD (chronic kidney disease) reduces LVMI [LV (left ventricular) mass index] and proteinuria. The MR can be activated by aldosterone, cortisol and DOC (deoxycorticosterone). The aim of the present study was to explore the influence of mineralocorticoids on LVMI and proteinuria in patients with CKD. A total of 70 patients with CKD and 30 patients with EH (essential hypertension) were recruited. Patients underwent clinical phenotyping; biochemical assessment and 24 h urinary collection for THAldo (tetrahydroaldosterone), THDOC (tetrahydrodeoxycorticosterone), cortisol metabolites (measured using GC-MS), and urinary electrolytes and protein [QP (proteinuira quantification)]. LVMI was measured using CMRI (cardiac magnetic resonance imaging). Factors that correlated significantly with LVMI and proteinuria were entered into linear regression models. In patients with CKD, significant predictors of LVMI were male gender, SBP (systolic blood pressure), QP, and THAldo and THDOC excretion. Significant independent predictors on multivariate analysis were THDOC excretion, SBP and male gender. In EH, no association was seen between THAldo or THDOC and LVMI; plasma aldosterone concentration was the only significant independent predictor. Significant univariate determinants of proteinuria in patients with CKD were THAldo, THDOC, USod (urinary sodium) and SBP. Only THAldo excretion and SBP were significant multivariate determinants. Using CMRI to determine LVMI we have demonstrated that THDOC is a novel independent predictor of LVMI in patients with CKD, differing from patients with EH. Twenty-four hour THAldo excretion is an independent determinant of proteinuria in patients with CKD. These findings emphasize the importance of MR activation in the pathogenesis of the adverse clinical phenotype in CKD.
Emily P McQuarrie; E Marie Freel; Patrick B Mark; Robert Fraser; Rajan K Patel; Henry G Dargie; John M C Connell; Alan G Jardine
Related Documents :
3250719 - Patient-controlled analgesia for burn patients: a preliminary report.
9201529 - Nitric oxide synthase inhibition by l-name in leukocytopenic patients with severe septi...
2916389 - Right ventricular dysfunction in septic shock: assessment by measurements of right vent...
6849639 - Determinants of organ malfunction or death in patients with intra-abdominal sepsis. a d...
11533009 - Effect of serum from different patient populations on the serum bactericidal test.
9793819 - Oral clonidine for sedation and analgesia in a burn patient.
11819709 - Morphological study on colonic pathology in ulcerative colitis treated by moxibustion.
3111169 - Growth hormone deficiency in adults--an indication for therapy?
19350119 - Microparticle-linked tissue factor activity and increased thrombin activity play a pote...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical science (London, England : 1979)     Volume:  123     ISSN:  1470-8736     ISO Abbreviation:  Clin. Sci.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-05-17     Completed Date:  2012-07-27     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  7905731     Medline TA:  Clin Sci (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  285-94     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldosterone / analogs & derivatives*,  urine
Biological Markers / urine
Cross-Sectional Studies
Desoxycorticosterone / analogs & derivatives*,  urine
Gas Chromatography-Mass Spectrometry
Hypertension / complications,  urine
Hypertrophy, Left Ventricular / etiology*,  urine
Linear Models
Magnetic Resonance Imaging
Middle Aged
Multivariate Analysis
Proteinuria / etiology*,  urine
Renal Insufficiency, Chronic / complications*,  urine
Sex Factors
Grant Support
G0400874//Medical Research Council; G0802803//Medical Research Council
Reg. No./Substance:
0/Biological Markers; 13489-75-3/tetrahydroaldosterone; 40GP35YQ49/Desoxycorticosterone; 4964P6T9RB/Aldosterone; 567-03-3/tetrahydrodeoxycorticosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Community based needs assessment in an urban area: a participatory action research project.
Next Document:  Preliminary clinical study of left ventricular myocardial strain in patients with non-ischemic dilat...